Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by investclubon Oct 26, 2020 10:36pm
180 Views
Post# 31786371

RE:At last a schedule

RE:At last a scheduleHi Fred 

Sherry's new compound is incredible my concern is it would be difficult to think of it down the road as a go alone or to replace TLD-1433 . Both Ruthenium & Osmium are found with Palladium and Platinum deposits but occur in as trace mineralization with Osmium being much less in occurence. I believe there was a grand total of roughly 350 to 400 lbs. mined last year in the USA . Perhaps the compounds developed from both Ruthenium & Osmium will have their own uses defined by Theralase as they approach other indications in clinical trials. I do know that currently Africa is the largest exporter of Ruthenium so maybe if Os-4T is to be used in future indications then adequate supplies can be contracted to produce the medical compound but currently Ruthenium is mined to sufficiently supply the company's needs as a gold standard to treat many cancer indications. 

Bullboard Posts